叶酸补充剂在中风预防中的有效性:一个元分析
Xiaobin Wang1, Xianhui Qin2, Hakan Demirtas3
1Mary Ann and J Milburn Smith Child Health Research Program, Children's Memorial Hospital and Children's Memorial Research Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Lancet (London, England)
|June 5, 2007
概括
叶酸补充剂显著降低了18%的中风风险. 这些好处在持续时间较长,同类半氨酸减少较大的试验中更为明显,这表明它在初级中风预防中的有效性.
科学领域:
- 心血管疾病研究研究
- 营养流行病学 营养流行病学
- 公共卫生干预措施 公共卫生干预措施
背景情况:
- 对于降低同类氨酸水平的治疗方法在预防心血管疾病方面的有效性仍有争议.
- 叶酸补充剂是减少中风风险的潜在干预措施.
研究的目的:
- 对预防中风的叶酸补充进行随机试验的元分析.
- 评估整体疗效并确定影响叶酸对中风风险影响的因素.
主要方法:
- 八项随机试验的元分析报告中风作为终点.
- 使用随机效应模型来计算中风的相对风险 (RR).
- 基于治疗持续时间,同型半氨酸降低,谷物强化和先前中风史的分层分析.
主要成果:
- 叶酸补充剂显示,中风风险降低了18% (RR 0.82,p=0.045).
- 治疗>36个月 (RR 0.71),降低同型半氨酸>20% (RR 0.77),没有/部分谷物强化 (RR 0.75) 和没有先前中风史 (RR 0.75) 观察到更大的益处.
结论:
- 叶酸补充剂有效降低中风风险.
- 通过补充叶酸可以增强中风的初级预防.
相关概念视频
Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
